Kevin Joseph Anstrom

Kevin Joseph Anstrom

Auto-generated profile, based on publicly available information

Kevin Joseph Anstrom

The University of North Carolina at Chapel Hill

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2020 in JMIR Medical Informatics
Verified
Journal Article
Open access
MSMark P Sendak
Mark P Sendak
WRWilliam Ratliff
William Ratliff
DSDina Sarro
Dina Sarro
EAElizabeth Alderton
Elizabeth Alderton
JFJoseph Futoma
Joseph Futoma
COCara O'Brien
Cara O'Brien
Background: Successful integrations of machine learning into routine clinical care are exceedingly rare, and barriers to its adoption are poorly characterized in the literature. Objective: This study aims to report a quality improvement effort to integrate a deep learning sepsis detection and management platform, Sepsis Watch, into routine clinical care. Methods: In 2016, a multidisciplinary team consisting of statisticians, data scientists, data engineers, and clinicians was assembled by the leadership of an academic health system to radically improve the detection and treatment of sepsis. This report of the quality improvement effort follows the learning health system framework to describe the problem assessment, design, development, implementation, and evaluation plan of Sepsis Watch. Results: Sepsis Watch was successfully integrated into routine clinical care and reshaped how local machine learning projects are executed. Frontline clinical staff were highly engaged in the design and development of the workflow, machine learning model, and application. Novel machine learning methods were developed to detect sepsis early, and implementation of the model required robust infrastructure. Significant investment was required to align stakeholders, develop trusting relationships, define roles and responsibilities, and to train frontline staff, leading to the establishment of 3 partnerships with internal and external research groups to evaluate Sepsis Watch. Conclusions: Machine learning models are commonly developed to enhance clinical decision making, but successful integrations of machine learning into routine clinical care are rare. Although there is no playbook for integrating deep learning into clinical care, learnings from the Sepsis Watch integration can inform efforts to develop machine learning technologies at other health care delivery systems.

1 January 2013 in Respiratory Research
Verified
Journal Article
Open access
PDF file
HCHarold R Collard
Harold R Collard
EYEric Yow
Eric Yow
LRLuca Richeldi
Luca Richeldi
KAKevin J Anstrom
Kevin J Anstrom
CGCraig Glazer
Craig Glazer
FIfor the IPFnet investigators
for the IPFnet investigators
Acute exacerbation of idiopathic pulmonary fibrosis has become an important outcome measure in clinical trials. This study aimed to explore the concept of suspected acute exacerbation as an outcome measure. Three investigators retrospectively reviewed subjects enrolled in the Sildenafil Trial of Exercise Performance in IPF who experienced a respiratory serious adverse event during the course of the study. Events were classified as definite acute exacerbation, suspected acute exacerbation, or other, according to established criteria. Thirty-five events were identified. Four were classified as definite acute exacerbation, fourteen as suspected acute exacerbation, and seventeen as other. Definite and suspected acute exacerbations were clinically indistinguishable. Both were most common in the winter and spring months and were associated with a high risk of disease progression and short-term mortality. In this study one half of respiratory serious adverse events were attributed to definite or suspected acute exacerbations. Suspected acute exacerbations are clinically indistinguishable from definite acute exacerbations and represent clinically meaningful events. Clinical trialists should consider capturing both definite and suspected acute exacerbations as outcome measures.

1 April 2017 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
MSMargaret L. Salisbury
Margaret L. Salisbury
DLDavid Lynch
David Lynch
EBEdwin J. R. van Beek
Edwin J. R. van Beek
EKElla A Kazerooni
Ella A Kazerooni
JGJunfeng Guo
Junfeng Guo
FIfor the IPFnet Investigators
for the IPFnet Investigators
Rationale: Adaptive multiple features method (AMFM) lung texture analysis software recognizes high-resolution computed tomography (HRCT) patterns. Objectives: To evaluate AMFM and visual quantification of HRCT patterns and their relationship with disease progression in idiopathic pulmonary fibrosis. Methods: Patients with idiopathic pulmonary fibrosis in a clinical trial of prednisone, azathioprine, and N-acetylcysteine underwent HRCT at study start and finish. Proportion of lung occupied by ground glass, ground glass–reticular (GGR), honeycombing, emphysema, and normal lung densities were measured by AMFM and three radiologists, documenting baseline disease extent and postbaseline change. Disease progression includes composite mortality, hospitalization, and 10% FVC decline. Measurements and Main Results: Agreement between visual and AMFM measurements was moderate for GGR (Pearson’s correlation r = 0.60, P < 0.0001; mean difference = −0.03 with 95% limits of agreement of −0.19 to 0.14). Baseline extent of GGR was independently associated with disease progression when adjusting for baseline Gender-Age-Physiology stage and smoking status (hazard ratio per 10% visual GGR increase = 1.98, 95% confidence interval [CI] = 1.20–3.28, P = 0.008; and hazard ratio per 10% AMFM GGR increase = 1.36, 95% CI = 1.01–1.84, P = 0.04). Postbaseline visual and AMFM GGR trajectories were correlated with postbaseline FVC trajectory (r = −0.30, 95% CI = −0.46 to −0.11, P = 0.002; and r = −0.25, 95% CI = −0.42 to −0.06, P = 0.01, respectively). Conclusions: More extensive baseline visual and AMFM fibrosis (as measured by GGR densities) is independently associated with elevated hazard for disease progression. Postbaseline change in AMFM-measured and visually measured GGR densities are modestly correlated with change in FVC. AMFM-measured fibrosis is an automated adjunct to existing prognostic markers and may allow for study enrichment with subjects at increased disease progression risk.

1 January 2017 in The American Journal of Cardiology
Verified
Journal Article
Closed access
JGJustin L. Grodin
Justin L. Grodin
JSJie-Lena Sun
Jie-Lena Sun
KAKevin J. Anstrom
Kevin J. Anstrom
HCHorng H. Chen
Horng H. Chen
RSRandall Starling
Randall Starling
WTW.H. Wilson Tang
W.H. Wilson Tang

27 November 2023 in Chest
Verified
Journal Article
Closed access
JKJohn S. Kim
John S. Kim
SMSusan Murray
Susan Murray
EYEric Yow
Eric Yow
KAKevin J. Anstrom
Kevin J. Anstrom
HKHyun J. Kim
Hyun J. Kim
INImre Noth
Imre Noth

1 January 2021 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
AGAndrea S Gershon
Andrea S Gershon
PLPeter K. Lindenauer
Peter K. Lindenauer
KWKevin C. Wilson
Kevin C. Wilson
LRLouise Rose
Louise Rose
AWAllan J. Walkey
Allan J. Walkey
JKJerry Krishnan
Jerry Krishnan
Rationale: Decisions in medicine are made on the basis of knowledge and reasoning, often in shared conversations with patients and families in consideration of clinical practice guideline recommendations, individual preferences, and individual goals. Observational studies can provide valuable knowledge to inform guidelines, decisions, and policy. Objectives: The American Thoracic Society (ATS) created a multidisciplinary ad hoc committee to develop a research statement to clarify the role of observational studies—alongside randomized controlled trials (RCTs)—in informing clinical decisions in pulmonary, critical care, and sleep medicine. Methods: The committee examined the strengths of observational studies assessing causal effects, how they complement RCTs, factors that impact observational study quality, perceptions of observational research, and, finally, the practicalities of incorporating observational research into ATS clinical practice guidelines. Measurements and Main Results: There are strengths and weakness of observational studies as well as RCTs. Observational studies can provide evidence in representative and diverse patient populations. Quality observational studies should be sought in the development of ATS clinical practice guidelines, and medical decision-making in general, when 1) no RCTs are identified or RCTs are appraised as being of low- or very low-quality (replacement); 2) RCTs are of moderate quality because of indirectness, imprecision, or inconsistency, and observational studies mitigate the reason that RCT evidence was downgraded (complementary); or 3) RCTs do not provide evidence for outcomes that a guideline committee considers essential for decision-making (e.g., rare or long-term outcomes; “sequential”). Conclusions: Observational studies should be considered in developing clinical practice guidelines and in making clinical decisions.